Skip to content

Helmet Continuous Positive Airway Pressure (CPAP) Versus Oxygen Venturi in Severe Acute Respiratory Failure in Pneumonia

A Prospective, Randomized, Controlled Trial to Evaluate the Efficacy of CPAP Delivered by Helmet in Comparison With Oxygen Therapy by Venturi Mask in Severe Acute Respiratory Failure Caused by Pneumonia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01383213
Enrollment
81
Registered
2011-06-28
Start date
2010-02-28
Completion date
2013-02-28
Last updated
2014-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia, Respiratory Insufficiency

Keywords

Acute Respiratory Failure, Pneumonia, Continuous Positive Airway Pressure

Brief summary

The purpose of this study is to compare the efficacy of CPAP application by a helmet and O2 administration by a Venturi mask in terms of achievement of criteria for endotracheal intubation during severe acute respiratory failure caused by pneumonia

Detailed description

Pneumonia is one of the commonest causes of hospitalised acute respiratory failure with a mortality rate up to 30%. Continuous Positive Airway Pressure (CPAP) has ben recently proved to be effective. To date, however, no prospective randomised study has been published on the comparison between CPAP and O2 administration by Venturi mask for the treatment of severe acute respiratory failure in patients with pneumonia. .

Interventions

OTHEROxygen therapy

patient in group oxygen therapy by Venturi Mask will be treated with oxygen until reaching clinical stability, or criteria of endotracheal intubation

patient in group CPAP will be treated with CPAP until reaching clinical stability, or criteria of endotracheal intubation

Sponsors

University of Milan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* men and women of any ethnic group; * age ≥18 years; * dyspnoea at rest with respiratory rate (RR) ≥30 breath/min or sign of respiratory distress * PaO2/FiO2 ratio≤250 evaluated during oxygen therapy supplied at least 1 hour through a Venturi mask with FiO2 ≥0,50 * diagnosis of pneumonia as unique cause of severe acute respiratory failure * informed consent from each patient or from the closest relative in case of the patient's incapacity to give it

Exclusion criteria

* diagnosis of other causes of severe acute respiratory failure * unstable angina or acute myocardial infarction; * acute respiratory acidosis with pH \<7,35 and PaCO2 \>45 mmHg; * systolic BP \<90 mmHg despite fluid resuscitation or vasopressors; * severe arrhythmias; * convulsions; * degree of consciousness, Kelly score\>3; * swallowing disturbance with increasing risk of aspiration pneumonia; * inability to protect the airway; * recent facial trauma or burn; * non-collaborative patient; * presence of open wounds (head, thorax, abdomen); * respiratory arrest or need of intubation; * pregnancy or suspect of pregnancy

Design outcomes

Primary

MeasureTime frameDescription
to Evaluate the Efficacy of CPAP (Group A) in Comparison With Oxygen Therapy With Venturi Mask (Group B, Standard Therapy) in Terms of Achievement of Criteria for Endotracheal Intubation.the reaching of the following endotracheal intubation criteria maintained for at least one hour:Endotracheale intubation criteria:≥1 among the major criteria or ≥2 among the minor criteria MAJOR CRITERIA:Respiratory arrest;Respiratory pauses with unconsciousness;Severe hemodynamic instability; Need of sedation MINOR CRITERIA:Reduction ≥ 30% of basal PaO2/FiO2; Increasing of 20% PaCO2 if basal PaCO2 is≥40mmHg; Worsening of alertness;Distress;SpO2\<90%;Exhaustion. The reaching of these criteria does not automatically imply the actual intubation of the patient, since this decision will depend on the treating physician.

Secondary

MeasureTime frameDescription
to Compare the Efficacy of the Two Treatments in Terms of In-hospital Mortalityparticipants will be followed for the duration of hospital stay, an expected average of 4 weeksThe secondary endpoint of this study will be evaluated, if appropriate, on 3 subpopulations composed of: 1. CPAP: patients randomised to CPAP treatment who have changed treatment only after the reaching of the primary endpoint 2. Control: patients randomised to Venturi mask treatment 3. Mixed: patients who, after the treatment with Venturi mask, have needed to be treated with non-invasive CPAP

Countries

Italy

Participant flow

Recruitment details

Feb. 2010-feb 2013 5 Italian High Dependence Units

Pre-assignment details

Exclusion criteria

Participants by arm

ArmCount
CPAP (Group A)
group A will be treated with CPAP using a helmet, initial PEEP of 10 cmH20 and an FiO2 set in order to maintain SpO2 ≥92%
40
Oxygen Therapy (Group B)
group B (standard treatment) will be treated with oxygen therapy by Venturi mask with an FiO2 set in order to maintain SpO2 ≥92%.
41
Total81

Baseline characteristics

CharacteristicOxygen Therapy (Group B)CPAP (Group A)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
28 Participants20 Participants48 Participants
Age, Categorical
Between 18 and 65 years
13 Participants20 Participants33 Participants
Age, Continuous69.5 years
STANDARD_DEVIATION 15.8
64.9 years
STANDARD_DEVIATION 16.1
67.2 years
STANDARD_DEVIATION 16
Region of Enrollment
Italy
41 participants40 participants81 participants
Sex: Female, Male
Female
12 Participants16 Participants28 Participants
Sex: Female, Male
Male
29 Participants24 Participants53 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 400 / 41
serious
Total, serious adverse events
2 / 407 / 41

Outcome results

Primary

to Evaluate the Efficacy of CPAP (Group A) in Comparison With Oxygen Therapy With Venturi Mask (Group B, Standard Therapy) in Terms of Achievement of Criteria for Endotracheal Intubation.

Endotracheale intubation criteria:≥1 among the major criteria or ≥2 among the minor criteria MAJOR CRITERIA:Respiratory arrest;Respiratory pauses with unconsciousness;Severe hemodynamic instability; Need of sedation MINOR CRITERIA:Reduction ≥ 30% of basal PaO2/FiO2; Increasing of 20% PaCO2 if basal PaCO2 is≥40mmHg; Worsening of alertness;Distress;SpO2\<90%;Exhaustion. The reaching of these criteria does not automatically imply the actual intubation of the patient, since this decision will depend on the treating physician.

Time frame: the reaching of the following endotracheal intubation criteria maintained for at least one hour:

ArmMeasureValue (NUMBER)
CPAP (Group A)to Evaluate the Efficacy of CPAP (Group A) in Comparison With Oxygen Therapy With Venturi Mask (Group B, Standard Therapy) in Terms of Achievement of Criteria for Endotracheal Intubation.6 participants
Oxygen Therapy (Group B)to Evaluate the Efficacy of CPAP (Group A) in Comparison With Oxygen Therapy With Venturi Mask (Group B, Standard Therapy) in Terms of Achievement of Criteria for Endotracheal Intubation.26 participants
Secondary

to Compare the Efficacy of the Two Treatments in Terms of In-hospital Mortality

The secondary endpoint of this study will be evaluated, if appropriate, on 3 subpopulations composed of: 1. CPAP: patients randomised to CPAP treatment who have changed treatment only after the reaching of the primary endpoint 2. Control: patients randomised to Venturi mask treatment 3. Mixed: patients who, after the treatment with Venturi mask, have needed to be treated with non-invasive CPAP

Time frame: participants will be followed for the duration of hospital stay, an expected average of 4 weeks

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026